Enterococcal bacteremia in a tertiary care centre in Winnipeg

Canadian Journal of Infectious Diseases

Volumn 10, Issue 1, 1999, Pages 57-63

  Madani, Tariq A A ^a   Kabani, Amin ^b   Orr, Pamela ^a   Nicolle, Lindsay ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Bacteremia; Enterococci; Nosocomial

Indexed keywords

VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; CANADA; ENTEROCOCCUS; FEMALE; HOSPITAL CARE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; TEACHING HOSPITAL;

EID: 0032936273     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/454985     Document Type: Article

References (34)

1. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infections. Am J Med 1991;91(Suppl 3B):72S-5S.
2. Moellering RC, Jr. Emergence of enterococcus as a significant pathogen. Clin Infect Dis 1992;14:1173-8.
3. Shlaes DM, Levy J, Wolinsky E. Enterococcal bacteremia without endocarditis. Arch Intern Med 1981;141:578-81.
4. Garrison RN, Fry DE, Berberich S, Polk HC. Enterococcal bacteremia: clinical implications and determinants of death. Ann Surg 1982;196:43-7.
5. Malone DA, Wagner RA, Myers JP, Watanakunakorn C. Enterococcal bacteremia in two large community teaching hospitals. Am J Med 1986;81:601-6.
6. Horan T, Culver D, Jarvis W, et al. Pathogens causing nosocomial infections. Preliminary data from the National Nosocomial Infections Surveillance System. Antimicrob Newslett 1988;57:105-7.
7. Zervos MJ, Dembinski S, Mikesell T, Schaberg DR. High-level resistance to gentamicin in Streptococcus faecalis: Risk factors and evidence for exogenous acquisition of infection. J Infect Dis 1986;153:1075-83.
8. Wells VD, Wong ES, Murray BE, Coudron PE, Williams DS, Markowitz SM. Infections due to beta-lactamase producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med 1992;116:285-92.
9. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morb Mortal Wkly Rep 1993;42:597-9.
10. Zervos MJ, Bacon AE III, Patterson JE, et al. Enterococcal superinfection in patients treated with ciprofloxacin. J Antimicrob Chemother 1988;21:113-5.
11. Jones RN. Gram-positive superinfection following beta-lactam chemotherapy: The significance of the enterococcus. Infection 1988;13(Suppl 1):S81-8.
12. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993;16:750-5.
13. Boyce JM, Opal SM, Potter-Boyne G, et al. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother 1992;36:1032-9.
14. Sapico FL, Canawati HN, Ginunas VJ, et al. Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem. J Clin Microbiol 1989;27:2091-5.
15. Patterson JE, Zervos MJ. High-level gentamicin resistance in enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis 1990;12:644-52.
16. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76-9.
17. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
18. Landry SL, Kaiser DL, Wenzel RP. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control 1989;17:323-9.
19. Huycke MM, Speigel CA, Gilmore MS. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1991;35:1626-34.
20. Noskin GA, Till M, Patterson BK, Clarke JT, Warren JR. High-level gentamicin resistance in Enterococcus faecalis bacteremia. J Infect Dis 1991;164:1212-5.
21. Antalek MD, Mylotte JM, Lesse AJ, Sellick JA Jr. Clinical and molecular epidemiology of Enterococcus faecalis bacteremia, with special reference to strains with high-level resistance to gentamicin. Clin Infect Dis 1995;20:103-9.
22. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 1989;27:731-4.
23. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing [NCCLS document M100-S5]. Villanova: National Committee for Clinical Laboratory Standards, 1994.
24. Murray, B, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990;28:2059-63.
25. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
26. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29(Suppl A):19-24.
27. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584-602.
28. Watanakunakorn C, Patel R. Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. Clin Infect Dis 1993;17:74-8.
29. Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996;156:1458-62.
30. McCarthy AE, Victor G, Ramotar K, Toye B. Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital. J Clin Microbiol 1994;32:2671-6.
31. Iwen PC, Kelly DM, Linder J, et al. Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob Agents Chemother 1997;41:494-5.
32. Gray J, Marsh PJ, Stewart D, Pedler SJ. Enterococcal bacteremia; a prospective study of 125 episodes. J Hosp Infect 1994;27:179-86.
33. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E faecium. Clin Infect Dis 1996;22:663-70.
34. Stroud L, Edwards J, Danzig L, Culver D, Gaynes R. Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol 1996;17:576-80.